Abstract: The present invention discloses a formaldehyde absorbent and a method for using the same, the chemical composition of the formaldehyde absorbent by weight percentage is, amino acid: 0.1-99.9%; DNA and RNA base 99.9-0.1%. The method comprises the following steps: a. dissolving the formaldehyde absorbent in solvent to form a solution or dissolving the formaldehyde absorbent in solvent and mixing the same onto a solid carrier; b. placing the solution or solid carrier in indoor space that contains formaldehyde; and c. contacting and reacting the formaldehyde-containing air with the solution or the solid carrier and then absorbing the same. The present invention not only achieves not only excellent performance in absorbing hazard gases in the air, but also features low-cost, and further causes no secondary pollution, which therefore creates great social and economical significance in improving quality of human life, safeguarding human health, and protecting environment.

Abstract: The present invention relates to an application of polyoxometalates with good water solubility in the preparation of disinfectant for sterilizing or removing formaldehyde. The present invention provides a sterilizing and disinfecting system utilizing oxygen in the air as an oxidizing agent, killing microorganisms via catalysis and oxidation, and particularly suitable for an air purification system. If the air is constantly introduced in, the disinfectant of the present invention can be used for a long time, without need of anti-viral drugs or peroxides having potential safety hazard, and without use of irritant substances containing halogen and alcohol having explosive hazard. Without using precious metals, the disinfectant system is easy to prepare and has low cost, dose not cause secondary pollution, and has a good application prospect.

Abstract: The present invention relates to an application of bisphenol salts in preparing a disinfectant used for sterilization or formaldehyde removal. The present invention provides a sterilization and disinfection system that uses oxygen in the air as oxidizer, kills microorganisms via catalyzed oxidation, and is particularly suitable in an air purification system. The disinfectant of the present invention can be used for an extended period of time insofar that air is continuously introduced, obviates the need for an anti-viral agent, also obviates the need for a peroxide that is potentially hazardous to safety, uses no halogen-containing irritating substance, and use no alcohol having risk of explosion. This disinfectant system that uses no precious metal is easy to prepare, low in use cost, and free of secondary pollution, and provides a good application prospect.

Abstract: The present invention discloses a formaldehyde absorbent and a method for using the same, the chemical composition of the formaldehyde absorbent by weight percentage is, amino acid: 0.1-99.9%; DNA and RNA base 99.9-0.1%. The method comprises the following steps: a. dissolving the formaldehyde absorbent in solvent to form a solution or dissolving the formaldehyde absorbent in solvent and mixing the same onto a solid carrier; b. placing the solution or solid carrier in indoor space that contains formaldehyde; and c. contacting and reacting the formaldehyde-containing air with the solution or the solid carrier and then absorbing the same. The present invention not only achieves not only excellent performance in absorbing hazard gases in the air, but also features low-cost, and further causes no secondary pollution, which therefore creates great social and economical significance in improving quality of human life, safeguarding human health, and protecting environment.

Abstract: A continuous reaction system is provided, which specifically relates to a continuous reaction system comprising subcritical and/or supercritical liquid as solvents and a reactant as solid. The invention can effectively prevent cavitations in the reaction system effectively, and realize maximum conversion of the solid reactant material.

Abstract: The present invention describes a method for the production of two highly purified enzymes capable of degrading chondroitin sulfate polysaccharides. A multi-step purification method incorporating cell disruption, cation exchange chromatography, affinity chromatography, hydroxylapatite chromatography, high resolution ion exchange chromatography and size exclusion is outlined. A 77,000.+-.5,000 Dalton protein capable of degrading chondroitin sulfates A and C and a 55,000.+-.2,300 Dalton protein capable of degrading dermatan sulfate were isolated. The genes encoding these enzymes, chondroitinase AC and chondroitinase B, respectively, have been cloned and methods for their use are described.

Abstract: The present invention describes a method for the production of two highly purified enzymes capable of degrading chondroitin sulfate polysaccharides. A multi-step purification method incorporating cell disruption, cation exchange chromatography, affinity chromatography, hydroxylapatite chromatography, high resolution ion exchange chromatography and size exclusion is outlined. A 77,000.+-.5,000 Dalton protein capable of degrading chondroitin sulfates A and C and a 55,000.+-.2,300 Dalton protein capable of degrading dermatan sulfate were isolated. The genes encoding these enzymes, chondroitinase AC and chondroitinase B, respectively, have been cloned and methods for their use are described.

Abstract: The present invention describes the isolation and sequence of genes from Flavobacterium heparinum encoding heparin and heparan sulfate degrading enzymes, heparinase II and heparinase III (EC 4.2.2.8). It further describes a method of expressing and an expression for heparinases I, II and III using a modified ribosome binding region derived from a promoter from glycosaminoglycan lyase genes of F. heparinum. Also, a multi-step protein purification method incorporating cell disruption, cation exchange chromatography, affinity chromatography and hydroxylapatite chromatography is outlined. Antibodies against a post-translational modification moiety common to Flavobacterium heparinum proteins and a method to obtain antibodies specific to these moieties and to the amino acid sequences of heparinases I, II and III are described.

Abstract: The present invention describes the isolation and sequence of genes from Flavobacterium heparinum encoding heparin and heparan sulfate degrading enzymes, heparinase II and heparinase III (EC 4.2.2.8). It further describes a method of expressing and an expression for heparinases I, II and III using a modified ribosome binding region derived from a promoter from glycosaminoglycan lyase genes of F. heparinum. Also, a multi-step protein purification method incorporating cell disruption, cation exchange chromatography, affinity chromatography and hydroxylapatite chromatography is outlined. Antibodies against a post-translational modification moiety common to Flavobacterium heparinum proteins and a method to obtain antibodies specific to these moieties and to the amino acid sequences of heparinases I, II and III are described.